@truthtracer Drawing nearer to a HBV Finite-Therapy might be a realism after all. And if so (HBV Finite T), especially if duration is long and durable, might accredit other future RNAi drugs to postulate superiority. $JNJ + $ARWR #JNJ-3989 #REEF 1-2 Triple Combo Data.